Literature DB >> 1777673

Structure and sequence analysis of the human activin beta A subunit gene.

K Tanimoto1, S Handa, N Ueno, K Murakami, A Fukamizu.   

Abstract

The cloned genomic DNA containing the human activin beta A subunit gene were analyzed by restriction endonuclease mapping, Southern blotting and DNA sequencing. The activin gene is composed of two exons interrupted by the 9-kb intron. The TATA, CCAAT and CT-stretch sequences were found in the 5'-flanking region of the gene. An intronic sequence contained SV40 enhancer core element in the vicinity of the exon 1. In the 3'-flanking region, we identified eight consensus polyadenylation sequences, five ATTTA motifs, CA element consisting of (CA)14, AP-1 binding site and two SV40 enhancer core elements. A dot matrix analysis revealed the high degree of conservation between the human and rat sequences within the 3'-flanking region, suggesting a possible functional significance.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1777673     DOI: 10.3109/10425179109039678

Source DB:  PubMed          Journal:  DNA Seq        ISSN: 1026-7913


  4 in total

1.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1992-08-11       Impact factor: 16.971

Review 2.  Inhibin at 90: from discovery to clinical application, a historical review.

Authors:  Yogeshwar Makanji; Jie Zhu; Rama Mishra; Chris Holmquist; Winifred P S Wong; Neena B Schwartz; Kelly E Mayo; Teresa K Woodruff
Journal:  Endocr Rev       Date:  2014-07-22       Impact factor: 19.871

3.  Presence of activin signal transduction in normal ovarian cells and epithelial ovarian carcinoma.

Authors:  I Ito; T Minegishi; J Fukuda; H Shinozaki; N Auersperg; P C Leung
Journal:  Br J Cancer       Date:  2000-04       Impact factor: 7.640

Review 4.  Research Progress on the Role and Mechanism of Action of Activin A in Brain Injury.

Authors:  Xiaojuan Su; Lingyi Huang; Dongqiong Xiao; Yi Qu; Dezhi Mu
Journal:  Front Neurosci       Date:  2018-10-09       Impact factor: 4.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.